The infusion drug that is now available - Tysabri - has a little better efficacy rate but a terrible safety profile.
现在已经可以提供混合性药物了——tysabri——这种药物的有效性略好于其它药品但却非常安全。
There was Avandia on Monday, Tysabri Tuesday, and acne treatment Accutane yesterday. Are we missing something today?
星期一是文迪雅,星期二是Tysabri,昨天是粉刺药异维甲酸,今天,我们会错过什么么?
应用推荐